Answers are grounded in this paper and cite their sources.
Artificial intelligence (AI) is increasingly used in cardiovascular research where conventional analysis struggles with scale, heterogeneity, and multimodal integration. Its contribution differs across imaging, computational omics, mechanistic simulation, and drug discovery. This narrative review examines substantive applications of machine learning and deep learning while distinguishing them from routine bioinformatics and purely biophysical modeling. We assess independent biological units, validation strategies, and strength of inference in representative studies. Deep-learning imaging systems can provide reproducible quantitative phenotypes, but workflow performance alone does not establish mechanism. In single-cell and spatial studies, clustering, integration, trajectory inference, and network reconstruction generally yield associations or hypotheses unless experimentally supported. Mechanistic interpretation is bounded by the specific effect established through targeted perturbation or rescue with functional testing; lineage tracing and orthogonal readouts provide complementary support, not standalone proof of causation. Hybrid AI-biophysical models may accelerate personalized simulation, whereas heart-on-chip, engineered tissue, and organoid systems without learned components are validation platforms rather than AI methods. In drug discovery, active learning and molecular redesign can prioritize candidates, but predicted reductions in ion-channel liability do not demonstrate biological safety or reduced proarrhythmic risk. Major limitations include pseudoreplication, data leakage, domain shift, batch effects, uncertain labels, few independent hearts, demographic imbalance, incomplete calibration, and limited transfer among animal, iPSC-derived, and adult human systems. AI is most valuable when it produces robust phenotypes or experimentally testable hypotheses within a transparent validation framework, rather than when predictive accuracy is treated as mechanistic evidence.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: